The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.75
Bid: 13.60
Ask: 13.90
Change: 0.00 (0.00%)
Spread: 0.30 (2.206%)
Open: 13.75
High: 13.75
Low: 13.75
Prev. Close: 13.75
POLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up

Mon, 12th Feb 2024 19:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Metals One PLC - Finland and Norway-focused developer of brownfield metals projects - Reports results from eight diamond drillholes at the R1 Hook target, located within the Rauta 9-11 licence area at the Black Schist Project in Finland. Says significant intersections of mineralised black schists were identified in all eight drill holes, whilst drilling has also demonstrated geological continuity with the company's existing Resource at R1 which could support future resource expansion.

----------

Beacon Energy PLC - Isle of Man-registered oil and gas company - Provides operational update on the Schwarzbach-2 well in the Erfelden field. Reports the sand jetting operation with a coiled tubing unit has now been completed. Expects to recommence production in the coming days following reinstallation of the rod pump. States the impact of the sand jetting will only be known once production has been restored and a stabilised and sustained flow rate from the rod pump has been achieved, at which time the company will provide an update. Once the well has been fully cleaned up following the sand jetting operations, it is expected that the rod pump will be replaced with an electrical submersible pump to maximise production - this is currently scheduled to take place in April 2024.

----------

Baron Oil PLC - London-based oil and gas exploration and appraisal company - Updates on operational activities on the TL-SO-19-16 production sharing contract, offshore Democratic Republic of Timor-Leste. Notes Baron's wholly owned subsidiary, SundaGas Banda Unipessoal Lda, has entered into contracts to conduct a survey at the planned drilling location for the Chuditch-2 appraisal well. Site survey operations are expected to be carried out at the location during February and early March 2024. Explains the objective of the site survey is principally to identify any potential hazards at the proposed well site, ensuring that a drilling rig can be safely located there with minimal environmental impact.

----------

Star Energy Group PLC - onshore energy company - Announces updated competent persons report for its conventional oil and gas interests. Reports proven reserves net present value of USD143 million at December 31, little changed from USD144 million in 2021. Says total of proven and probable reserves was USD235 million at December 31, rising from USD215 million in 2021.

----------

Poolbeg Pharma PLC - London-based clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need - Says independent research conducted on behalf of Poolbeg confirms a more than USD10 billion market opportunity for POLB 001 in cancer immunotherapy-induced cytokine release syndrome as an orally delivered preventative therapy. Believes rare and orphan diseases represent a significant value creation opportunity. Sees a substantial opportunity for medicines to treat these severe and often chronic conditions. Anticipates that acquiring and commercialising rare and orphan drugs could potentially lead to attractive revenue generation opportunities.

----------

Kromek Group PLC - Sedgefield, England-based detection technology supplier - Agrees to allot new shares to another two loan note holders in consideration of them cancelling their loan notes that were due to expire later this month. This follows loan note conversion announced last Monday. The two further loan note holders will cancel their loan notes, which total GBP1.2 million, including accrued interest. Kromek agrees to allot around 16.5 million shares in consideration of the cancellation at 7.5 pence per share. The cancellation is subject to shareholder approval.

----------

Katoro Gold PLC - London-based gold and nickel exploration and development company - Raises GBP750,000 via broker-led placing and subscription with new and existing shareholders to support business development at 0.1 pence per share. Plans changes to board to maximise value from existing interests and to secure new cost-effective opportunities globally, with a focus on critical metals including uranium. Appoints strategic consultant, Paul Johnson, former chief executive of Power Metal Resources PLC and Metal Tiger PLC, to assist the board with a reinvigoration of the business model, business operations, strategic direction and enhanced communications with investors. Plans name change to Katoro Global Resources PLC.

----------

Enteq Technologies PLC - Ascot, England-based energy services technology and equipment supplier - Provides an update on the progress of the SABER Tool technology. Expects to receive USD100,000 in the first half of financial 2025 from contract win.

----------

Silverwood Brands PLC - holding company established to invest primarily in branded consumer businesses - Says VSA Capital Ltd has transferred around 2.3 million shares to Chief Executive Andrew Gerrie in settlement of a legal dispute. Following this transfer, finalises arrangements for the proposed cancellation of the 228 million shares issued in connection with the acquisition of a 20% stake in Lush Cosmetics Ltd and Lush Cosmetic Warriors.

----------

Athelney Trust PLC - invests in smaller UK companies for dividend and capital growth - Reports net asset value at December 31 was 209.1 pence, down 4.7% from 219.4p the year before. Recommends final dividend of 7.6p, making a total payout of 9.8p, increased from 9.6p, a rise of 2.0%. NAV total return was negative 4.4% compared to negative 26.2% the year before. Describes the year as "disappointing". Notes the company suffered negative absolute returns and has underperformed compared to the FTSE 250 largely because of ongoing negative sentiment for UK smaller companies and comparatively high UK interest rates through the year. But, believes there is now a strong case for investment in UK equities....which "offer great value for money".

----------

RTW Biotech Opportunities Ltd - London-based venture capital firm focused on biotechnology companies - Notes Arix shareholders vote to place Arix Bioscience PLC into voluntary liquidation. Following this, the assets of Arix have been transferred to RTW in exchange for the issue of new ordinary shares in RTW Bio to eligible Arix shareholders. In November, RTW agreed to acquire the entirety of Arix's assets, with shareholders receiving 1.4633 RTW shares for each share in the company. RTW also provided a cash exit to Arix's largest shareholder, Acacia Research Corp, which has been given a total of USD57.1 million in exchange for its 26% stake in the company.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
20 Jul 2022 12:04

IN BRIEF: Poolbeg Pharma shares rise as first human trial begins

Poolbeg Pharma PLC - London-based pharmaceutical company - Receives approval to commence its Lipopolysaccharide human clinical trial for POLB 011, a drug that aims to treat severe influenza. The trial will formally start on Friday. It will assess POLB 011 in damping the immune response to lipopolysaccharide, which acts as a surrogate for the hyperinflammatory response associated with severe influenza. Initial results are expected in the final quarter of 2022. Poolbeg says at that point it intends to "rapidly" monetise by out-licensing and/or partnering with pharmaceutical and biotechnology companies for the drug's further development.

Read more
27 Jun 2022 10:47

Poolbeg Pharma AI model of respiratory syncytial virus starts analysis

(Alliance News) - Poolbeg Pharma PLC on Monday said its build and optimisation of an artificial intelligence model of respiratory syncytial virus data is complete.

Read more
27 May 2022 10:43

AIM WINNERS & LOSERS: Premier Miton advances; Advance Energy retreats

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
26 May 2022 16:54

IN BRIEF: Poolbeg Pharma shares soar on US patent grants

Poolbeg Pharma PLC - London-based pharmaceutical company - Wins patent grants from the US Patent & Trademark Office for its POLB 001 and POLB 002 molecules. The former is used to treat influenza, while the latter is an RNA-based immunotherapy for respiratory virus infections. "The company is continuing working with its patent advisors to broaden and expand the POLB 001 and POLB 002 patent families," Poolbeg says.

Read more
26 May 2022 10:51

AIM WINNERS & LOSERS: Poolbeg wins patents; RA swings to loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
12 May 2022 15:35

TRADING UPDATES: Secure Trust lending up; Eurocell sales climb

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Apr 2022 20:15

IN BRIEF: Poolbeg hails shareholder confidence as lock-up period ends

Poolbeg Pharma PLC - London-based pharmaceutical company - Confirms proposals have been accepted by distribution in specie shareholders seeking to sell a total of GBP366,000 of Poolbeg shares, representing only 3% of the distribution in specie shares. Says 97% of distribution in specie shareholders have decided to remain invested in Poolbeg following the end of the lock-up period.

Read more
14 Apr 2022 21:36

TRADING UPDATES: Polar Capital assets up; Brooks Macdonald funds fall

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
14 Apr 2022 14:53

Poolbeg granted European patent for antiviral nose spray

(Sharecast News) - Clinical-stage pharmaceutical company Poolbeg Pharma reported on the strengthening of its intellectual property (IP) for its 'POLB 002' asset on Thursday - a first-in-class, intranasally-administered RNA-based immunotherapy for respiratory virus infections.

Read more
13 Apr 2022 19:46

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
11 Apr 2022 21:58

TRADING UPDATES: TruFin raises GBP10 million, Afentra preferred bidder

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Apr 2022 10:57

AIM WINNERS & LOSERS: Mothercare misses payment; Argos licence renewed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
31 Mar 2022 21:07

TRADING UPDATES: SSE's Transmission raises cash; Croda gets UK grant

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
30 Mar 2022 19:25

IN BRIEF: Poolbeg Pharma starts trading on OTCQB Venture Market

Poolbeg Pharma PLC - London-based pharmaceutical company - Shares start trading on the OTCQB Venture Market in the US.

Read more
28 Mar 2022 15:10

UK shareholder meetings calendar - next 7 days

Tuesday 29 March 
Impax Asset Management Group PLCAGM
Tekmar Group PLCAGM
Wednesday 30 March 
Brunner Investment Trust PLCAGM
Mediazest PLCAGM
Micro Focus International PLCAGM
Parsley Box Group PLCGM re equity raise
Power Metal Resources PLCGM re carried forward losses
Power Metal Resources PLCAGM
Thursday 31 March 
Pressure Technologies PLCAGM
Red Rock Resources PLCAGM
Aukett Swanke Group PLCAGM
Various Eateries PLCAGM
Toople PLCAGM
BiVictriX Therapeutics PLCAGM
CloudCoCo Group PLCAGM
Friday 1 April 
Gfinity PLCGM re fundraising
River & Mercantile Group PLCAGM
Monday 4 April 
Poolbeg Pharma PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.